BusinessWire Latest Clinical Data of InnoCare’s Gunagratinib Presented at 2023 ASCO GI Business Wire News Jan 26, 2023 BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the development of therapies for cancer and autoimmune diseases, announced today that the latest clinical result of FGFR…